Technology Transfer (Technology & Engineering) Team
Dr Adam Daykin
Head of Technology Transfer
Adam has over 20 years’ experience of technology commercialisation. Having obtained a PhD in Materials in 1990 and following that worked as a post-doc, he moved to QinetiQ, first to project management and then to business group management. In 2002 he moved to healthcare company Weston Medical as IP manager and then spent a period at NHS Innovations London, specialising in medical devices. During his 13+ years at QMI, Adam been responsible for establishing 16 spin-out companies worth circa £160m at peak and executed in excess of 60 income generating technology licences.
+44 (0)207 882 5117
Ben has over 2 years’ experience in technology commercialisation. Following an undergraduate degree in Biochemistry, including a year with GSK, he moved from pharmaceuticals into engineering, and is currently completing a PhD in Tissue Engineering & Regenerative Medicine from the University of Leeds. During his PhD, he joined Medipex, the Yorkshire-based healthcare innovation hub, where he was responsible for managing the development of new medical devices from NHS Trusts across the region and advising on IP strategy. At QMI, Ben is responsible for the output from the Institute of Bioengineering.
Dr Jim Shaikh
Senior Commercialisation Manager
Jim has over 16 years’ experience in early stage venture development having established and exited three businesses. Following a PhD from Cambridge University in 1993, Jim followed an academic route with a post-doctoral post at Cambridge and a lectureship at Queen Mary. He left academia in 1997 to join BMW/Rover, introducing simulation technology into the vehicle development process before moving into Engineering Consulting. Jim completed a MBA at London Business School in 2004 and started and exited two engineering businesses before founding a consumer products business in 2009 based on a patented technology. He raised investment and grew the business over a period of 10 years, establishing distribution in 20 international markets before exiting. Jim has joined QMI with a focus on Science & Technology and supporting Queen Mary’s spin-out portfolio.
Technology Transfer (BioPharma) Team
Dr Michele Hill-Perkins
Head of Technology Transfer
Michele started her career as a research scientist in academia and then the biotechnology industry. She has held senior business development roles at Cancer Research Technology and the Wellcome Trust where she was involved in licensing transactions and the provision of “development gap” funding to spin-out companies in the biotechnology and pharmaceutical sector. Prior to joining QMI, Michele worked as Project Director at Partnerships UK in the science commercialisation team, advising public sector organisations on commercial strategy, and also in its venture capital arm, PUK Ventures, advising on life science and medtech investments. Michele was investment manager at the Children’s Investment Fund Foundation responsible for investments in child survival. Michele has a PhD in biochemistry, an MSc from University College, London and an MA (Oxon) in Human Sciences.
Tel: +44 (0)20 7882 5581
Mob: +44 (0)7825402975
Dr Liisa Chisty
Liisa trained as a scientist and her post-doctoral work involved the development of a biosensor for single-stranded DNA on project funded by MRCT (LifeArc). She worked as the primary scientist designing the project and experiments and contributed to the drafting of the patent as an inventor and management of the project with an MRCT technology transfer manager. Liisa joined QMI after holding several roles at technology transfer offices across London. These include IP management and commercialisation roles at Imperial Innovations and UCL Business, and at Ximbio, Cancer Research UK, and covered technologies from biopharma to natural sciences. At Ximbio, Liisa’s role included management of relationships and new accounts with universities and research institutes in the UK, Scandinavia, Baltics and Australasia.
Liisa holds a 1st class honours degree in Molecular Genetics from King’s College London, and a PhD from UCL, which she completed on a Wellcome Trust Interdisciplinary PhD Programme in Structural, Chemical and Computational Biology and the experimental work was done at MRC National Institute for Medical Research. Liisa also has several years of experience in self-employment.
At QMI, Liisa helps to commercialisation technologies from the Biopharma sector.
Tel: +44 (0)20 7882 5278
Mob: +44 (0)7717693507
Reitesh joined QMI in 2008 and became Finance Director in 2012. He is responsible for the financial oversight of the company and its subsidiaries. Prior to QMI, he worked in new media for over seven years and gained valuable insight into managing the finances of a growing company. Reitesh has been a member of the Chartered Institute of Management Accountants for over 15 years.
+44 (0)207 882 5117
Safo is responsible for managing the College’s patent portfolio which includes database, renewals and contracts management as well as liaising with academics, patent attorneys, licensees and with the Technology Transfer Managers. Prior to joining QMI in 2008, she worked for six years at Sharp Laboratories of Europe Ltd as a patent administrator. She started her career in Qiagen KK’s BioRobot Team in Tokyo.
+44 (0)207 882 5123
Innovation China UK (ICUK)
Manyi has been working in the UK higher education knowledge transfer field over the last 20 years and leading the Global Innovation Partners/ICUK programme since 2007. She also serves as the Board Directors of Queen Mary Research and Consulting (Hong Kong) Limited and Mary Education Management Advisory (Beijing) Co. Ltd. She is a frequent contributor to the UK government policy research in UK-China joint innovation, intellectual property protection and technology commercialisation. Before joining the public sector, Manyi was the founding member and senior executive of two technology start-ups specialised in wireless Bioinformatics and Engineering, responsible for in international business development and technology licensing based in London and Shanghai over 8 years. Manyi has BSc in Civil Engineering from Tongji University, a MBA in Innovation Management from Imperial College London, and a LLM in Intellectual Property Laws from University of London.
+44 (0)207 882 8341
Senior Partnership Manager, Newton Fund and Commercialisation
Charlie supports the Global Innovation Partners team with international collaborations and commercialisation. Charlie has over 10 years’ experience working at the interface between academia and industry and fostering successful partnerships. In 2012, Charlie successfully delivered a programme aimed at providing business support and encouraging student entrepreneurship in collaboration with corporate partners Microsoft and BAE systems at the National Centre for Entrepreneurship for Education (NCEE). Before joining the Global Innovation Partnerships team, he supported academic researchers to develop collaborations with industry partners and helped foster strategically important institutional partnerships as Business Development Manager (Science and Engineering) at Queen Mary University of London (QMUL).
Phoebe (Qiong) Wang
Partnership and Communications Manager
Phoebe supports the Global Innovation Partners/Innovation China UK Program team with international collaborations. Before joining QMI, Qiong was Assistant Director (Research) for the Centre for Energy and Environmental Policy Research at Beijing Institute of Technology for 3 years. Qiong developed her passion for identifying solutions and strategies to energy problems and climate finance mechanisms whilst working at the Research Centre for Climate and Energy Finance at the Central University of Finance and Economics and the Department of Industrial and Systems Engineering at the National University of Singapore.
+44 7775 411 898
An Excellent & Dynamic Team
If you would like to find out more information about our technologies or have any queries, please contact the relevant team member using our contact information found on our team profiles.